Actavis has made a strong start to the new year by extending its portfolio of products launched on day one of patent expiry, within the first three weeks of 2012.

Latanoprost and Latanoprost/Timolol Eye Drops Solution are the latest additions to Actavis’ existing range of medicines for the treatment of glaucoma and ocular hypertension.

Michael Cann, director generics said: “Actavis has over 550 medicines available in the UK and continues to develop a competitively priced, broad portfolio of products with a focus on day one patent expiries.”

All products are available through major wholesalers or directly from the Actavis Customer Service team on telephone: 0800 731 0370 or fax: 0800 731 0380.